Collineau, B.; Gonçalves, A.; Domon, M.; Bruyat, D.; Bertucci, F.; de Nonneville, A.
Toxicity Profiles of Antibody–Drug Conjugates: Synthesis and Graphical Insights to Optimize Patient-Centered Treatment Strategies for HER2-Negative Metastatic Breast Cancer. Cancers 2025, 17, 2307.
https://doi.org/10.3390/cancers17142307
AMA Style
Collineau B, Gonçalves A, Domon M, Bruyat D, Bertucci F, de Nonneville A.
Toxicity Profiles of Antibody–Drug Conjugates: Synthesis and Graphical Insights to Optimize Patient-Centered Treatment Strategies for HER2-Negative Metastatic Breast Cancer. Cancers. 2025; 17(14):2307.
https://doi.org/10.3390/cancers17142307
Chicago/Turabian Style
Collineau, Bérénice, Anthony Gonçalves, Marie Domon, Damien Bruyat, François Bertucci, and Alexandre de Nonneville.
2025. "Toxicity Profiles of Antibody–Drug Conjugates: Synthesis and Graphical Insights to Optimize Patient-Centered Treatment Strategies for HER2-Negative Metastatic Breast Cancer" Cancers 17, no. 14: 2307.
https://doi.org/10.3390/cancers17142307
APA Style
Collineau, B., Gonçalves, A., Domon, M., Bruyat, D., Bertucci, F., & de Nonneville, A.
(2025). Toxicity Profiles of Antibody–Drug Conjugates: Synthesis and Graphical Insights to Optimize Patient-Centered Treatment Strategies for HER2-Negative Metastatic Breast Cancer. Cancers, 17(14), 2307.
https://doi.org/10.3390/cancers17142307
